HomeCompareSMTS vs MRK

SMTS vs MRK: Dividend Comparison 2026

SMTS yields 48.12% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMTS wins by $300.6K in total portfolio value
10 years
SMTS
SMTS
● Live price
48.12%
Share price
$0.20
Annual div
$0.10
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$357.4K
Annual income
$70,244.76
Full SMTS calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SMTS vs MRK

📍 SMTS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMTSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMTS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMTS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMTS
Annual income on $10K today (after 15% tax)
$4,090.23/yr
After 10yr DRIP, annual income (after tax)
$59,708.05/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SMTS beats the other by $51,379.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMTS + MRK for your $10,000?

SMTS: 50%MRK: 50%
100% MRK50/50100% SMTS
Portfolio after 10yr
$207.1K
Annual income
$40,021.45/yr
Blended yield
19.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SMTS
Analyst Ratings
3
Buy
2
Hold
Consensus: Buy
Price Target
$1.50
+651.9% upside vs current
Range: $1.50 — $1.50
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMTS buys
0
MRK buys
0
No recent congressional trades found for SMTS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMTSMRK
Forward yield48.12%2.76%
Annual dividend / share$0.10$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$357.4K$56.8K
Annual income after 10y$70,244.76$9,798.13
Total dividends collected$282.6K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$1.50$128.54

Year-by-year: SMTS vs MRK ($10,000, DRIP)

YearSMTS PortfolioSMTS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,512$4,812.03$11,206$366.19+$4.3KSMTS
2$23,574$6,976.11$12,650$502.35+$10.9KSMTS
3$35,132$9,908.18$14,407$694.19+$20.7KSMTS
4$51,392$13,800.16$16,585$967.82+$34.8KSMTS
5$73,855$18,866.30$19,342$1,363.89+$54.5KSMTS
6$104,365$25,339.16$22,913$1,947.19+$81.5KSMTS
7$145,134$33,464.05$27,662$2,823.89+$117.5KSMTS
8$198,786$43,492.19$34,159$4,173.35+$164.6KSMTS
9$268,373$55,672.81$43,337$6,308.80+$225.0KSMTS
10$357,404$70,244.76$56,776$9,798.13+$300.6KSMTS

SMTS vs MRK: Complete Analysis 2026

SMTSStock

Sierra Metals Inc., together with its subsidiaries, focuses on the production, exploration, and development of precious and base metals in Peru and Mexico. It primarily focuses on exploration of silver, copper, lead, zinc, and gold deposits. The company's flagship property is the 81.84% owned polymetallic Yauricocha Mine covering an area of 18,778 hectares located in the Yauyos province in Peru. It also holds 100% interest in the Bolivar mine, comprising of 12 mining concessions covering an area 15,217 hectares; and Cusi Mines that comprises of 73 concessions covering 11,977 hectares in Mexico. The company was formerly known as Dia Bras Exploration Inc. and changed its name to Sierra Metals Inc. in December 2012. Sierra Metals Inc. was incorporated in 1996 and is headquartered in Toronto, Canada.

Full SMTS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SMTS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMTS vs SCHDSMTS vs JEPISMTS vs OSMTS vs KOSMTS vs MAINSMTS vs JNJSMTS vs ABBVSMTS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.